TB

Rapid Communication: Molecular assays as initial tests for the diagnosis of tuberculosis and rifampicin resistance

This material aims to inform national TB Programmes and other stakeholders about the key implications of the latest evidence on the use of specific molecular assays as initial diagnostic tests of pulmonary and extrapulmonary TB and RR-TB, in adults and children.

Back to Results

Child Tuberculosis Fact Sheet

This fact sheet highlights data on TB in children, information on the neglect of TB in children, and new tools available for TB testing and treatment.

Back to Results

Medication Tracker: The 4 Months Daily Rifampin Schedule for Latent Tuberculosis (TB) Infection

This tool provides a daily Rifampin Schedule for Latent Tuberculosis (TB) patients.

Back to Results

Latent Tuberculosis Infection Treatment Regimens

This info sheet summarizes the updated 2020 LTBI treatment guidelines that apply to persons with LTBI who live in the United States

Back to Results

Tuberculosis in the United States (2018 slide set)

This slide set presents surveillance data based on TB case reports for 1993–2017 received by CDC.

Back to Results

Treatment for Latent Tuberculosis (TB) Infection: Isoniazid and Rifapentine (INH-RPT)

This fact sheet provides information regarding the 12-dose regimen for treating latent TB infection.

Back to Results

Generic Programmatic and Clinical Guide for the Introduction of new drugs and Shorter Regimens for the Treatment of Multi/Extensively Drug-Resistant Tuberculosis

This document describes the steps necessary to implement the shorter regimen and the new drugs for drug-resistant TB treatment, including diagnosis and bacterial confirmation of drug resistance, treatment regimen design, monitoring of treatment efficacy and safety, and programmatic evaluation.

Back to Results

What You Need to Know About Your Medicine for Latent Tuberculosis (TB) Infection – Isoniazid and Rifapentine

This Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.

Back to Results

An Activist’s Guide to Tuberculosis Diagnostic Tools

This guide provides an overview of TB diagnostic tools and suggests recommendations for how activists and clinicians can contribute to improved TB diagnosis.

Back to Results

MMWR: Exposure of Passengers and Flight Crew to Mycobacterium Tuberculosis on Commercial Aircraft, 1992-1995.

This report summarizes CDC and State health departments investigations and provides guidance about notification of passengers and flight crew after exposure to TB during travel on commercial aircrafts. From January 1993 through February 1995, CDC and State health departments completed an investigation of six instances in which passengers or flight crew traveled on commercial aircraft while infectious with TB.

Back to Results

First
Previous
1
2
3
4
5
6
7
8
9
Next
Last

TB

CDC NPIN Resources